SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-13-042817
Filing Date
2013-02-07
Accepted
2013-02-07 11:56:35
Documents
1
Group Members
JAMES NIEDELJEANI DELAGARDELLENEW LEAF VENTURE MANAGEMENT I, L.L.C.NEW LEAF VENTURE MANAGEMENT I, L.P.PHILIPPE O. CHAMBONRONALD HUNTSRINIVAS AKKARAJUVIJAY LATHI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 2 d479846dsc13da.htm SC 13D/A 185594
  Complete submission text file 0001193125-13-042817.txt   187512
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Subject) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81821 | Film No.: 13580920
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 TIMES SQUARE SUITE 1603 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 1603 NEW YORK NY 10036 646-871-6400
New Leaf Ventures I, L.P. (Filed by) CIK: 0001375661 (see all company filings)

IRS No.: 260137799 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A